• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型双组份混合真皮支架的设计用于治疗压疮。

Design of a Novel Two-Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores.

机构信息

Regenerative Biomaterials Group, RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Northwood, HA6 2RN, UK.

Department of Biochemical Engineering, University College London, Gower Street, London, WC1E 6BT, UK.

出版信息

Macromol Biosci. 2017 Nov;17(11). doi: 10.1002/mabi.201700185. Epub 2017 Sep 12.

DOI:10.1002/mabi.201700185
PMID:28895290
Abstract

The aim of this study is to design a novel two-component hybrid scaffold using the fibrin/alginate porous hydrogel Smart Matrix combined to a backing layer of plasma polymerized polydimethylsiloxane (Sil) membrane to make the fibrin-based dermal scaffold more robust for the treatment of the clinically challenging pressure sores. A design criteria are established, according to which the Sil membranes are punched to avoid collection of fluid underneath. Manual peel test shows that native silicone does not attach to the fibrin/alginate component while the plasma polymerized silicone membranes are firmly bound to fibrin/alginate. Structural characterization shows that the fibrin/alginate matrix is intact after the addition of the Sil membrane. By adding a Sil membrane to the original fibrin/alginate scaffold, the resulting two-component scaffolds have a significantly higher shear or storage modulus G'. In vitro cell studies show that dermal fibroblasts remain viable, proliferate, and infiltrate the two-component hybrid scaffolds during the culture period. These results show that the design of a novel two-component hybrid dermal scaffold is successful according to the proposed design criteria. To the best of the authors' knowledge, this is the first study that reports the combination of a fibrin-based scaffold with a plasma-polymerized silicone membrane.

摘要

本研究旨在设计一种新型的两组件混合支架,使用纤维蛋白/海藻酸钠多孔水凝胶 Smart Matrix 与等离子体聚合聚二甲基硅氧烷 (Sil) 膜的背衬层相结合,使基于纤维蛋白的真皮支架更坚固,以治疗临床上具有挑战性的压疮。根据设计标准,Sil 膜被打孔以避免在其下方积液。手动剥离试验表明,天然硅酮不会附着在纤维蛋白/海藻酸盐成分上,而等离子体聚合的硅酮膜则牢固地结合在纤维蛋白/海藻酸盐上。结构特征表明,在添加 Sil 膜后,纤维蛋白/海藻酸盐基质保持完整。通过在原始纤维蛋白/海藻酸盐支架上添加 Sil 膜,得到的两组件支架的剪切或储能模量 G'显著增加。体外细胞研究表明,在培养期间,真皮成纤维细胞保持存活、增殖并渗透到两组件混合支架中。这些结果表明,根据提出的设计标准,新型两组件混合真皮支架的设计是成功的。据作者所知,这是首次报道将基于纤维蛋白的支架与等离子体聚合的硅酮膜结合的研究。

相似文献

1
Design of a Novel Two-Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores.新型双组份混合真皮支架的设计用于治疗压疮。
Macromol Biosci. 2017 Nov;17(11). doi: 10.1002/mabi.201700185. Epub 2017 Sep 12.
2
Viscoelastic, physical, and bio-degradable properties of dermal scaffolds and related cell behaviour.真皮支架的粘弹性、物理和生物降解特性以及相关细胞行为。
Biomed Mater. 2016 Sep 2;11(5):055001. doi: 10.1088/1748-6041/11/5/055001.
3
Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon-caprolactone)-fibrin hybrid scaffold.响应与新型聚(ε-己内酯)-纤维蛋白混合支架整合的信号分子而产生的血管组织
J Tissue Eng Regen Med. 2007 Sep-Oct;1(5):389-97. doi: 10.1002/term.48.
4
Shape-memory porous alginate scaffolds for regeneration of the annulus fibrosus: effect of TGF-β3 supplementation and oxygen culture conditions.用于纤维环再生的形状记忆多孔海藻酸盐支架:TGF-β3补充和氧气培养条件的影响
Acta Biomater. 2014 May;10(5):1985-95. doi: 10.1016/j.actbio.2013.12.037. Epub 2013 Dec 28.
5
Autologous fibrin scaffolds cultured dermal fibroblasts and enriched with encapsulated bFGF for tissue engineering.自体纤维蛋白支架培养的成纤维细胞,并与包封的 bFGF 一起用于组织工程。
J Biomed Mater Res A. 2011 Dec 15;99(4):648-54. doi: 10.1002/jbm.a.33231. Epub 2011 Sep 27.
6
Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering.直接沉积多孔磷酸钙水泥海藻酸盐支架用于药物输送和骨组织工程。
Acta Biomater. 2011 Aug;7(8):3178-86. doi: 10.1016/j.actbio.2011.04.008. Epub 2011 Apr 27.
7
Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors.用于控制递呈促血管生成生长因子的聚(醚)氨酯-聚二甲基硅氧烷-纤维蛋白复合材料支架的组织反应。
Biomaterials. 2010 Jul;31(20):5336-44. doi: 10.1016/j.biomaterials.2010.03.033. Epub 2010 Apr 9.
8
Functional stability of endothelial cells on a novel hybrid scaffold for vascular tissue engineering.新型血管组织工程杂交支架内皮细胞功能稳定性。
Biofabrication. 2010 Dec;2(4):041001. doi: 10.1088/1758-5082/2/4/041001. Epub 2010 Sep 24.
9
Use of Clotted Human Plasma and Aprotinin in Skin Tissue Engineering: A Novel Approach to Engineering Composite Skin on a Porous Scaffold.凝血人血浆和抑肽酶在皮肤组织工程中的应用:在多孔支架上构建复合皮肤的新方法。
Tissue Eng Part C Methods. 2015 Oct;21(10):1098-104. doi: 10.1089/ten.TEC.2014.0667. Epub 2015 Jun 30.
10
A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors.一种基于复合纤维蛋白的支架,用于控制生物活性促血管生成生长因子的释放。
J Control Release. 2010 Feb 25;142(1):14-21. doi: 10.1016/j.jconrel.2009.09.029. Epub 2009 Oct 5.

引用本文的文献

1
From bench to bedside: the research status and application opportunity of extracellular vesicles and their engineering strategies in the treatment of skin defects.从 bench 到床边:细胞外囊泡及其工程策略在皮肤缺损治疗中的研究现状与应用机遇
J Nanobiotechnology. 2025 May 25;23(1):375. doi: 10.1186/s12951-025-03461-4.
2
Blood Plasma, Fibrinogen or Fibrin Biomaterial for the Manufacturing of Skin Tissue-Engineered Products and Other Dermatological Treatments: A Systematic Review.用于制造皮肤组织工程产品及其他皮肤科治疗的血浆、纤维蛋白原或纤维蛋白生物材料:一项系统综述
J Funct Biomater. 2025 Feb 22;16(3):79. doi: 10.3390/jfb16030079.
3
Topical hADSCs-HA Gel Promotes Skin Regeneration and Angiogenesis in Pressure Ulcers by Paracrine Activating PPARβ/δ Pathway.
局部注射富含脂肪间充质干细胞的透明质酸凝胶通过旁分泌激活过氧化物酶体增殖物激活受体β/δ通路促进压迫性溃疡的皮肤再生和血管生成。
Drug Des Devel Ther. 2024 Oct 26;18:4799-4824. doi: 10.2147/DDDT.S474628. eCollection 2024.
4
Polymeric biomaterials for wound healing.用于伤口愈合的高分子生物材料。
Front Bioeng Biotechnol. 2023 Jul 27;11:1136077. doi: 10.3389/fbioe.2023.1136077. eCollection 2023.
5
Advance in topical biomaterials and mechanisms for the intervention of pressure injury.局部生物材料及压力性损伤干预机制的研究进展
iScience. 2023 May 26;26(6):106956. doi: 10.1016/j.isci.2023.106956. eCollection 2023 Jun 16.
6
Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects.聚-ε-己内酯/纤维蛋白-海藻酸盐支架:一种用于治疗骨缺损的新型促血管生成复合生物材料。
Polymers (Basel). 2021 Oct 2;13(19):3399. doi: 10.3390/polym13193399.
7
Stem cell and tissue engineering approaches in pressure ulcer treatment.干细胞和组织工程方法在压疮治疗中的应用。
J Spinal Cord Med. 2023 Mar;46(2):194-203. doi: 10.1080/10790268.2021.1916155. Epub 2021 Apr 27.
8
Pro-angiogenic and osteogenic composite scaffolds of fibrin, alginate and calcium phosphate for bone tissue engineering.用于骨组织工程的纤维蛋白、藻酸盐和磷酸钙促血管生成和成骨复合支架
J Tissue Eng. 2021 Apr 6;12:20417314211005610. doi: 10.1177/20417314211005610. eCollection 2021 Jan-Dec.
9
Pre-screening the intrinsic angiogenic capacity of biomaterials in an optimised chorioallantoic membrane model.在优化的鸡胚绒毛尿囊膜模型中对生物材料的内在血管生成能力进行预筛选。
J Tissue Eng. 2020 Feb 4;11:2041731420901621. doi: 10.1177/2041731420901621. eCollection 2020 Jan-Dec.
10
The importance of factorial design in tissue engineering and biomaterials science: Optimisation of cell seeding efficiency on dermal scaffolds as a case study.析因设计在组织工程和生物材料科学中的重要性:以优化真皮支架上的细胞接种效率为例
J Tissue Eng. 2018 Jun 25;9:2041731418781696. doi: 10.1177/2041731418781696. eCollection 2018 Jan-Dec.